From: Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
Characteristics | All patients (N = 961) | The lower group | The higher group | p value |
---|---|---|---|---|
(ChE < 7700 U/L, N = 482) | (ChE > = 7700 U/L, N = 479) |  | ||
Sex | ||||
 Female | 340 (35.40)c | 136 (28.20)c | 204 (42.60)c | < 0.001 |
 Male | 621 (64.60)c | 346 (71.80)c | 275 (57.40)c |  |
Age at diagnosis (Years) | 61.15 (10.67)a | 63.10 (10.92)a | 59.18 (10.04)a | < 0.001 |
Ethnicity | ||||
 Minority | 89 (9.30)c | 55 (11.40)c | 34 (7.10)c | 0.041 |
 Han majority | 872 (90.70)c | 427 (88.60)c | 445 (92.90)c |  |
Smoking | ||||
 No | 384 (40.00)c | 169 (35.10)c | 215 (44.90)c | 0.003 |
 Yes | 577 (60.00)c | 313 (64.90)c | 264 (55.10)c |  |
BMI (kg/m2) | 23.74 (35.88)a | 24.36 (50.63)a | 23.14 (6.58)a | 0.603 |
Chemotherapy | ||||
 No | 443 (46.10)c | 239 (49.60)c | 204 (42.60)c | 0.035 |
 Yes | 518 (53.90)c | 243 (50.40)c | 275 (57.40)c |  |
Complications | ||||
 No | 521 (54.20)c | 262 (54.40)c | 259 (54.10)c | 0.981 |
 Yes | 440 (45.80)c | 220 (45.60)c | 220 (45.90)c |  |
Histological type | ||||
 Adenocarcinoma | 628 (65.30)c | 283 (58.70)c | 345 (72.00)c | < 0.001 |
 Squamous cell carcinoma | 291 (30.30)c | 177 (36.70)c | 114 (23.80)c |  |
 Large cell carcinoma | 8 (0.80)c | 6 (1.20)c | 2 (0.40)c |  |
 Multiple types | 34 (3.50)c | 16 (3.30)c | 18 (3.80)c |  |
Stage | ||||
 Early stage | 84 (8.70)c | 29 (6.00)c | 55 (11.50)c | 0.004 |
 Advanced stage | 877 (91.30)c | 453 (94.00)c | 424 (88.50)c |  |
Survival length (Day) | 374.00 (147.00, 717.00)b | 276.74 (107.00, 587.75)b | 483.43 (219.00, 841.50)b | < 0.001 |
ALB (U/L) | 42.50 (38.57, 45.20)b | 39.95 (35.86, 42.99)b | 44.19 (42.10, 46.60)b | < 0.001 |
NLR (Unit free) | 2.95 (1.97, 4.36)b | 3.43 (2.22, 5.20)b | 2.53 (1.83, 3.46)b | < 0.001 |
ChE (U/L) | 7700.00 (6287.00, 8900.00)b | – | – |  |